Company Announcements

On March 3, 2023, Nuclera unveiled their new Global headquarters, One Vision Park in Impington, Cambridge, UK, about a year following the company’s successful Series B raise. The event, marking a new chapter in its history and creating a new space to drive the future growth.  The building was inaugurated by The Rt Hon Lucy…

Colin Barnes (left) and Kristine Friscino (right) CAMBRIDGE, UK (May, 2022) – Nuclera, a biotechnology company accelerating protein expression workflows, has announced the appointment of two new members of their team: Colin Barnes, as VP of Intellectual Property and Kristine Friscino, as AVP of Marketing. “We are so excited to have both Colin and Kristine on…

Eugene Bragin (left) and Charu Maini (right) CAMBRIDGE, UK (May, 2022) – Nuclera, pioneers of benchtop protein printing technologies, this week announced the appointment of two new members of the Nuclera team: Charu Maini, as VP of People, and Eugene Bragin, as VP of Software. “We are excited to welcome Charu and Eugene to the…

Nuclera’s new state of the art facilities near Boston CAMBRIDGE, UK (18 Jan 2022) – Nuclera, a Cambridge, UK-based biotech company developing cutting-edge benchtop protein printing technologies, announces the opening of its US subsidiary located in Boston, MA. The addition of this new US facility in the rapidly growing biotechnology hub of greater Boston USA…